Professor Andrea Brancale
Projects as PI
- The first preclinical analysis for a novel magnetically directed cancer treatment (01/08/2016 - 30/04/2017)
- Translation of bacterial mediated therapeutic RNAi of solid tumours by demonstrating PARP inhibition in preclinical trials (30/06/2018 - 15/11/2018)
- Welsh anti-microbial testing platform (01/06/2015 - 31/12/2018)
- Welsh Coronavirus Research (W-CoRe): A platform for the discovery of anti-betacoronaviruses agents (15/10/2020 - 31/03/2021)
- Welsh NRN Life Sciences Health Related Biosciences Workshop (01/08/2017 - 31/01/2018)
Projects as Co-Investigator
- Computer-aided design, synthesis and evaluation of novel antiviral agents against Norovirus (08/01/2018 - 07/01/2019)
- Derivation of a companion diagnostic for the novel anti-metastatic agent CB1 (01/09/2018 - 30/11/2018)
- Design and synthesis of molecular inhibitors of c-FLIP activity as a therapeutic strategy to target breast cancer stem cells (01/10/2012 - 30/09/2015)
- Design, synthesis and evaluation of novel agents to treat retinal blinding disease, Leber's congenital amaurosis (01/09/2015 - 30/11/2016)
- Developing carbon-monoxide (CO) as synergistic agent to improve anti-VEFG strategy for triple-negative breast cancer (01/10/2015 - 30/09/2018)